Tamar Ben-Yedidia
Chief Tech/Sci/R&D Officer en SCINAI IMMUNOTHERAPEUTICS LTD. .
Perfil
Tamar Ben-Yedidia is currently the Chief Science Officer at Scinai Immunotherapeutics Ltd.
since 2004.
Prior to this, she worked as a Lab Manager at Biotechnology General (Israel) Ltd.
from 1991 to 1994.
Dr. Ben-Yedidia received her undergraduate degree from Tel-Aviv University and her doctorate degree from Weizmann Institute of Science in 2000.
Cargos activos de Tamar Ben-Yedidia
Empresas | Cargo | Inicio |
---|---|---|
SCINAI IMMUNOTHERAPEUTICS LTD. | Chief Tech/Sci/R&D Officer | 01/01/2004 |
Antiguos cargos conocidos de Tamar Ben-Yedidia.
Empresas | Cargo | Fin |
---|---|---|
Biotechnology General (Israel) Ltd.
Biotechnology General (Israel) Ltd. Pharmaceuticals: MajorHealth Technology Biotechnology General (Israel) Ltd. manufactures and markets pharmaceutical products. Its products include Aminopeptidase B, Euflexxa, Zomacton, BioTropin, and Carboxypeptidase. The firm has operations in Europe, Japan, and the United States. The company was founded in 1980 and is headquartered in Kiryat Malachi, Israel | Corporate Officer/Principal | 01/01/1994 |
Formación de Tamar Ben-Yedidia.
Tel-Aviv University | Undergraduate Degree |
Weizmann Institute of Science | Doctorate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
Empresas cotizadas | 1 |
---|---|
SCINAI IMMUNOTHERAPEUTICS LTD. | Health Technology |
Empresas privadas | 1 |
---|---|
Biotechnology General (Israel) Ltd.
Biotechnology General (Israel) Ltd. Pharmaceuticals: MajorHealth Technology Biotechnology General (Israel) Ltd. manufactures and markets pharmaceutical products. Its products include Aminopeptidase B, Euflexxa, Zomacton, BioTropin, and Carboxypeptidase. The firm has operations in Europe, Japan, and the United States. The company was founded in 1980 and is headquartered in Kiryat Malachi, Israel | Health Technology |
- Bolsa de valores
- Insiders
- Tamar Ben-Yedidia